These statements have not been evaluated to diagnose, treat, cure, or prevent any disease
Watson KT, Wroolie TE, Tong G, Foland-Ross LC, Frangou S, Singh M, et al
The drugs are approved by the FDA as treatments for obesity and diabetes
escalate gradually to minimize GI effects.[1][10] Individualized Dosing Considerations : Start at 1-2 mg
The intersection of nutrition and peptide therapy is one of the most important but least discussed aspects of getting optimal results from any GLP-1 medication
The SURMOUNT-4 randomized clinical trial found that adults who continued tirzepatide maintained and improved weight reduction, while those switched to placebo regained weight